Thursday, May 12, 2016 2:39 AM
|
CCSVI Alliance
This is not good news for another MS drug! Mitoxantrone, a drug commonly prescribed for multiple sclerosis could be associated with an increased risk for developing some forms of cancer, a new study reports.
|